These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Differential expression of claudin 1, 3, and 4 during normal mammary gland development in the mouse. Blanchard AA; Watson PH; Shiu RP; Leygue E; Nistor A; Wong P; Myal Y DNA Cell Biol; 2006 Feb; 25(2):79-86. PubMed ID: 16460231 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus receptor expression in normal and diseased liver tissue. Reynolds GM; Harris HJ; Jennings A; Hu K; Grove J; Lalor PF; Adams DH; Balfe P; Hübscher SG; McKeating JA Hepatology; 2008 Feb; 47(2):418-27. PubMed ID: 18085708 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations. Krieger SE; Zeisel MB; Davis C; Thumann C; Harris HJ; Schnober EK; Mee C; Soulier E; Royer C; Lambotin M; Grunert F; Dao Thi VL; Dreux M; Cosset FL; McKeating JA; Schuster C; Baumert TF Hepatology; 2010 Apr; 51(4):1144-57. PubMed ID: 20069648 [TBL] [Abstract][Full Text] [Related]
11. Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry. Riva L; Song OR; Prentoe J; Helle F; L'homme L; Gattolliat CH; Vandeputte A; Fénéant L; Belouzard S; Baumert TF; Asselah T; Bukh J; Brodin P; Cocquerel L; Rouillé Y; Dubuisson J J Virol; 2018 May; 92(10):. PubMed ID: 29491159 [TBL] [Abstract][Full Text] [Related]
12. In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection. Mailly L; Wrensch F; Heydmann L; Fauvelle C; Brignon N; Zeisel MB; Pessaux P; Keck ZY; Schuster C; Fuerst TR; Foung SKH; Baumert TF Antiviral Res; 2019 Feb; 162():136-141. PubMed ID: 30599173 [TBL] [Abstract][Full Text] [Related]
13. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma. Chao YC; Pan SH; Yang SC; Yu SL; Che TF; Lin CW; Tsai MS; Chang GC; Wu CH; Wu YY; Lee YC; Hong TM; Yang PC Am J Respir Crit Care Med; 2009 Jan; 179(2):123-33. PubMed ID: 18787218 [TBL] [Abstract][Full Text] [Related]
14. Correlation of the tight junction-like distribution of Claudin-1 to the cellular tropism of hepatitis C virus. Yang W; Qiu C; Biswas N; Jin J; Watkins SC; Montelaro RC; Coyne CB; Wang T J Biol Chem; 2008 Mar; 283(13):8643-53. PubMed ID: 18211898 [TBL] [Abstract][Full Text] [Related]
15. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Evans MJ; von Hahn T; Tscherne DM; Syder AJ; Panis M; Wölk B; Hatziioannou T; McKeating JA; Bieniasz PD; Rice CM Nature; 2007 Apr; 446(7137):801-5. PubMed ID: 17325668 [TBL] [Abstract][Full Text] [Related]
16. Tight junction dysfunction in the stratum granulosum leads to aberrant stratum corneum barrier function in claudin-1-deficient mice. Sugawara T; Iwamoto N; Akashi M; Kojima T; Hisatsune J; Sugai M; Furuse M J Dermatol Sci; 2013 Apr; 70(1):12-8. PubMed ID: 23433550 [TBL] [Abstract][Full Text] [Related]
17. Discovery of anti-claudin-1 antibodies as candidate therapeutics against hepatitis C virus. Yamashita M; Iida M; Tada M; Shirasago Y; Fukasawa M; Nagase S; Watari A; Ishii-Watabe A; Yagi K; Kondoh M J Pharmacol Exp Ther; 2015 Apr; 353(1):112-8. PubMed ID: 25628391 [TBL] [Abstract][Full Text] [Related]
18. Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody. Mailly L; Xiao F; Lupberger J; Wilson GK; Aubert P; Duong FHT; Calabrese D; Leboeuf C; Fofana I; Thumann C; Bandiera S; Lütgehetmann M; Volz T; Davis C; Harris HJ; Mee CJ; Girardi E; Chane-Woon-Ming B; Ericsson M; Fletcher N; Bartenschlager R; Pessaux P; Vercauteren K; Meuleman P; Villa P; Kaderali L; Pfeffer S; Heim MH; Neunlist M; Zeisel MB; Dandri M; McKeating JA; Robinet E; Baumert TF Nat Biotechnol; 2015 May; 33(5):549-554. PubMed ID: 25798937 [TBL] [Abstract][Full Text] [Related]
19. Changes in the distribution pattern of Claudin tight junction proteins during the progression of mouse skin tumorigenesis. Arabzadeh A; Troy TC; Turksen K BMC Cancer; 2007 Oct; 7():196. PubMed ID: 17945025 [TBL] [Abstract][Full Text] [Related]
20. Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudins. Hopcraft SE; Evans MJ Hepatology; 2015 Oct; 62(4):1059-69. PubMed ID: 25820616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]